Business
Novo Holdings to make changes to its Board of Directors
Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step down as Chair.
About this update from Novo Nordisk A/s Class B
[{"type":"text","content":"COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ -- Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step down as Chair.","length":266,"tagName":"p"},{"type":"text","content":"Lars Green has more than 30 years of leadership experience in the healthcare and life science industries.","length":105,"tagName":"p"},{"type":"text","content":"He joined Novo Nordisk in 1992 and has held various financial leadership positions in the company, including regional CFO roles in Japan and North America, before joining Executive Management in 2017. In 2019, Lars Green joined Novozymes (Novonesis) where he served as CFO until the end of 2023.","length":295,"tagName":"p"},{"type":"text","content":"He became a member of the Board of Novo Holdings earlier this year and is also a member of the Board of the Novo Nordisk Foundation. In addition, he holds several other board positions, including as member of the boards of LEO Pharma and H. Lundbeck.","length":250,"tagName":"p"},{"type":"text","content":"Lars Green will assume the role as Chair after Lars Rebien Sørensen, who has been Chair of Novo Holdings since 2018. Earlier today, the Novo Nordisk Foundation announced (INSERT LINK) that it proposes the election of Lars Rebien Sørensen as Chair of Novo Nordisk A/S for a limited period of time, with the company today calling for an extraordinary general meeting to elect new members to its Board on November 14. In connection with the election, Lars Rebien Sørensen will step down as Chair of Novo Holdings.","length":510,"tagName":"p"},{"type":"text","content":"Furthermore, Novo Holdings will elect Britt Meelby Jensen as new Vice Chair of the Board. Britt Meelby Jensen has held several leadership positions throughout her career and is currently CEO of Ambu. In 2024, she was voted 'Leader of the year' by Lederne, Denmark's biggest organisation for leaders. She has been a member of the Novo Holdings Board since 2022.","length":372,"tagName":"p"},{"type":"text","content":"Britt Meelby Jensen will assume the Vice Chair role after Steen Riisgaard who has been Vice Chair since 2018. Steen Riisgaard will remain on the Novo Holdings Board until the expiry of his term in April 2026, at which point he will reti...